Anzeige
Mehr »
Sonntag, 06.07.2025 - Börsentäglich über 12.000 News
LiquidLink startet Bitcoin Lightning- und XRP-ILP-Nodes - Aufbau des Rückgrats der tokenisierten Finanzwelt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
214 Leser
Artikel bewerten:
(1)

Global Home Infusion Therapy Market to Surpass $49.5 Billion despite the Rise of COVID-19 Crisis - Exclusive Report [165 pages] by Research Dive

  • The COVID-19 pandemic has positively impacted the global home infusion therapy market growth in 2020
  • The rising prevalence of chronic disorders and growing adoption of home infusion therapy are boosting the market growth during the pandemic period

PUNE, India, Aug. 20, 2020 /PRNewswire/ --

COVID-19 has Positive Impact on Global Home Infusion Therapy Market

Research Dive has added a new research report on the Global Home Infusion Therapy Market to its repository. The report divulges the impact of COVID-19 pandemic on the current and future growth of the global market. This report is a thorough research study formulated by experts by analyzing major driving factors, regional market conditions, newest trends and advances, and size & scope of the market during the disaster period.

Research Dive Logo

Highlights of COVID-19 Impact on Home Infusion Therapy Market Report

The abrupt rise of the COVID-19 pandemic has created an optimistic impact on the global home infusion therapy market. As per the report, the global home infusion therapy market was valued at $20.2 billion in 2019 and is estimated to hit $49.5 billion by 2027, rising at a CAGR of 11.7% during the crisis period. The size of the market in the present circumstances has stretched up to $22.9 billion owing to the augmented adoption of home infusion treatment by chronic disease patients during the COVID-19 chaos.

Download COVID-19 Impact Analysis Report at https://www.researchdive.com/covid-19-insights/360/home-infusion-therapy-marketmyQueryForm

Factors Boosting the Market Growth amidst COVID-19 Pandemic

The global home infusion therapy market is anticipated to observe substantial growth owing to the worldwide increase in the cases of severe diseases and rise in geriatric population that requires long-term therapeutic treatments. Additionally, mounting preference for home-based treatment by patients, having low immunity, in order to avoid getting infected by the COVID-19 infection is increasing the demand for home infusion therapy; hence, resulting in an increased growth of the market.

Current Market Scenario Due to COVID-19:

Many leading players in the home infusion therapy market are performing various strategies such as partnerships, collaborations, and new product developments to withstand their market position during the crisis period. For instance, in July 2020, Voluntis, a healthcare software company specialized in Patient Relationship Management (PRM), and Biocon biologics, an advanced and fully integrated biopharmaceutical firm, has partnered to develop and provide cutting-edge digital therapeutics based on biologics therapy for aiding diabetes patients.

On the other hand, government bodies in many COVID-19 infected regions are offering support to the home infusion therapy companies to sustain their business amidst the COVID-19 catastrophe. For instance, in October 2019, the Medicare & Medicaid Services Centers have passed a law announcing that all home infusion therapy expenditures will get covered under the Bipartisan Budget Act of 2018.

Avail Discount: 10% Off on Customization https://www.researchdive.com/request-for-customization/360

Future Prospective of the Market:

As per the report, the global home infusion therapy market is anticipated to experience constant growth post-coronavirus pandemic.

Top Players in Home Infusion Therapy Market

  1. Eli Lilly and Company
  2. COSMED srl
  3. Baxter International, Inc.
  4. Smiths Medical.
  5. JMS Co., Ltd.
  6. ICU Medical Inc.
  7. Dickinson and Company (BD)
  8. Terumo Corporation
  9. Fresenius Kabi
  10. Becton, Dickinson and Company
  11. B Braun Melsungen AG

And others are expected to mold the future of the global home infusion therapy market in the upcoming years.

Moreover, the report offers a brief summary of business overview including financial performance, product portfolio, recent strategic moves & developments, and SWOT analysis of all key players of the market. Inquire before Purchase [75 page] Summary Report

Read More About home Infusion Therapy:

Home Infusion Therapy Can Be an Ideal Option for Obtaining Healthcare Amidst COVID-19 Turmoil, Here's how

Increasing Geriatric Population Across The Globe Is Predicted To Boost The Home Infusion Therapy Market

Similar Reports:

  1. Energy-based Cancer Treatment Market: Global Opportunity Analysis and Industry Forecast, 2019-2026 - Download Sample Report
  2. Laboratory Testing Market: Global Opportunity Analysis and Industry Forecast, 2020-2027 - Download Sample Report

About Research Dive

Research Dive is a market research firm based in Pune, India. Maintaining the integrity and authenticity of the services, the firm provides the services that are solely based on its exclusive data model, compelled by the 360-degree research methodology, which guarantees comprehensive and accurate analysis. With an unprecedented access to several paid data resources, team of expert researchers, and strict work ethic, the firm offers insights that are extremely precise and reliable. Scrutinizing relevant news releases, government publications, decades of trade data, and technical & white papers, Research dive deliver the required services to its clients well within the required timeframe. Its expertise is focused on examining niche markets, targeting its major driving factors, and spotting threatening hindrances. Complementarily, it also has a seamless collaboration with the major industry aficionado that further offers its research an edge.

Contact:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York NY 10005
(P) +91-(788)-802-9103 (India)
+1-(917)-444-1262 (US)
Toll Free: 1-888-961-4454
E-mail: support@researchdive.com
Website: https://www.researchdive.com
Blog: https://www.researchdive.com/blog/
LinkedIn: https://www.linkedin.com/company/research-dive/
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive-1385542314927521

Logo: https://mma.prnewswire.com/media/997523/Research_Dive_Logo.jpg

© 2020 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.